Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE)

M. Linker-Israeli, A. C. Bakke, R. C. Kitridou, Sandra J Gendler, S. Gillis, D. A. Horwitz

Research output: Contribution to journalArticle

338 Citations (Scopus)

Abstract

The objective of this study was to define some causes of the immunologic impairment characteristic of systemic lupus erythematosus. Blood mononuclear cells from 19 patients were stimulated to produce interleukin 1 and interleukin 2 and compared with controls. A severe defect in both IL 1 and IL 2 activity was observed. The low cytokine levels did not correlate with clinical or serologic activity of disease. These defects could not be explained by concurrent corticosteroid therapy. There was no correlation between a lower number of OKT4+ cells observed in these patients and the levels of IL 2 production, nor did removal of monocytes bring IL 2 to normal. Impaired IL 2 production could not be restored to normal by IL 1. The observed deficiency in these regulatory cytokines may therefore be a primary defect that is important in the pathogenesis of this disorder.

Original languageEnglish (US)
Pages (from-to)2651-2655
Number of pages5
JournalJournal of Immunology
Volume130
Issue number6
StatePublished - 1983
Externally publishedYes

Fingerprint

Interleukin-1
Systemic Lupus Erythematosus
Interleukin-2
Cytokines
Monocytes
Blood Cells
Adrenal Cortex Hormones
Cell Count
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Linker-Israeli, M., Bakke, A. C., Kitridou, R. C., Gendler, S. J., Gillis, S., & Horwitz, D. A. (1983). Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). Journal of Immunology, 130(6), 2651-2655.

Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). / Linker-Israeli, M.; Bakke, A. C.; Kitridou, R. C.; Gendler, Sandra J; Gillis, S.; Horwitz, D. A.

In: Journal of Immunology, Vol. 130, No. 6, 1983, p. 2651-2655.

Research output: Contribution to journalArticle

Linker-Israeli, M, Bakke, AC, Kitridou, RC, Gendler, SJ, Gillis, S & Horwitz, DA 1983, 'Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE)', Journal of Immunology, vol. 130, no. 6, pp. 2651-2655.
Linker-Israeli, M. ; Bakke, A. C. ; Kitridou, R. C. ; Gendler, Sandra J ; Gillis, S. ; Horwitz, D. A. / Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). In: Journal of Immunology. 1983 ; Vol. 130, No. 6. pp. 2651-2655.
@article{b76616add05849fcb1e3c9e5651b88ad,
title = "Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE)",
abstract = "The objective of this study was to define some causes of the immunologic impairment characteristic of systemic lupus erythematosus. Blood mononuclear cells from 19 patients were stimulated to produce interleukin 1 and interleukin 2 and compared with controls. A severe defect in both IL 1 and IL 2 activity was observed. The low cytokine levels did not correlate with clinical or serologic activity of disease. These defects could not be explained by concurrent corticosteroid therapy. There was no correlation between a lower number of OKT4+ cells observed in these patients and the levels of IL 2 production, nor did removal of monocytes bring IL 2 to normal. Impaired IL 2 production could not be restored to normal by IL 1. The observed deficiency in these regulatory cytokines may therefore be a primary defect that is important in the pathogenesis of this disorder.",
author = "M. Linker-Israeli and Bakke, {A. C.} and Kitridou, {R. C.} and Gendler, {Sandra J} and S. Gillis and Horwitz, {D. A.}",
year = "1983",
language = "English (US)",
volume = "130",
pages = "2651--2655",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "6",

}

TY - JOUR

T1 - Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE)

AU - Linker-Israeli, M.

AU - Bakke, A. C.

AU - Kitridou, R. C.

AU - Gendler, Sandra J

AU - Gillis, S.

AU - Horwitz, D. A.

PY - 1983

Y1 - 1983

N2 - The objective of this study was to define some causes of the immunologic impairment characteristic of systemic lupus erythematosus. Blood mononuclear cells from 19 patients were stimulated to produce interleukin 1 and interleukin 2 and compared with controls. A severe defect in both IL 1 and IL 2 activity was observed. The low cytokine levels did not correlate with clinical or serologic activity of disease. These defects could not be explained by concurrent corticosteroid therapy. There was no correlation between a lower number of OKT4+ cells observed in these patients and the levels of IL 2 production, nor did removal of monocytes bring IL 2 to normal. Impaired IL 2 production could not be restored to normal by IL 1. The observed deficiency in these regulatory cytokines may therefore be a primary defect that is important in the pathogenesis of this disorder.

AB - The objective of this study was to define some causes of the immunologic impairment characteristic of systemic lupus erythematosus. Blood mononuclear cells from 19 patients were stimulated to produce interleukin 1 and interleukin 2 and compared with controls. A severe defect in both IL 1 and IL 2 activity was observed. The low cytokine levels did not correlate with clinical or serologic activity of disease. These defects could not be explained by concurrent corticosteroid therapy. There was no correlation between a lower number of OKT4+ cells observed in these patients and the levels of IL 2 production, nor did removal of monocytes bring IL 2 to normal. Impaired IL 2 production could not be restored to normal by IL 1. The observed deficiency in these regulatory cytokines may therefore be a primary defect that is important in the pathogenesis of this disorder.

UR - http://www.scopus.com/inward/record.url?scp=0020546709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020546709&partnerID=8YFLogxK

M3 - Article

C2 - 6222112

AN - SCOPUS:0020546709

VL - 130

SP - 2651

EP - 2655

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 6

ER -